Heart Attack Therapy
Study data from Duke University, Department of Medicine update knowledge of heart attack therapy
Published in Drug Law Weekly, November 13th, 2007
A report, 'A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling,' is newly published data in Proceedings of the National Academy of Sciences of the United States of America. "For many years, beta-adrenergic receptor antagonists (beta-blockers or betaAR antagonists) have provided significant morbidity and mortality benefits in patients who have sustained acute myocardial infarction. More recently, beta-adrenergic receptor antagonists have been found to provide survival benefits in patients suffering from heart failure, although the efficacy of different beta-blockers varies widely in this condition," scientists in the United States report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-11-13)
More Articles from Drug Law Weekly
- Alcoholism Therapy
Studies from RTI International reveal new findings on alcoholism therapy - Autism
International Hyperbarics Association Sponsors the National Autism Conference, Atlanta - Breast Cancer
Minnesota Hormone Therapy Lawsuit Dismissed - Chronic Bronchitis
Adams Respiratory Therapeutics Receives Approvable Letter From FDA for Mucinex(R) With Codeine - Dermatology
Nycomed Signs Definitive Agreement to Acquire Bradley Pharmaceuticals, Inc., Strengthening US Specialty Business - Drug Delivery
Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
